Seleccione otro país
Bienvenido a Lyxor España
Por favor, lea la información importante aquí incluida antes de continuar a nuestra página web

Información relevante 

Los Lyxor ETFs presentados en la página web de lyxoretf.com, pueden ser objeto de restricciones en lo que respecta a la inversión por determinadas personas o en determinados países, en virtud de las distintas regulaciones nacionales aplicables a dichas personas o en dichos países. Cualquier persona que acceda a esta página web desde una jurisdicción en la cual se aplican dichas restricciones tiene que informarse al respecto y observar dichas restricciones. Por consiguiente, le corresponde a usted asegurarse de que, efectivamente está autorizado a invertir en los Lyxor ETFs presentados en esta página web. Invirtiendo en estos productos, usted garantiza a Société Générale que está efectivamente autorizado a invertir. Inversores españoles se deben dirigir a www.lyxoretf.es

La información contenida en esta página web no constituye una oferta o invitación para adquirir o vender los productos aquí descritos a personas sometidas a  jurisdicciones donde:

(a) dicha oferta o invitación no esté autorizada;
(b) Lyxor Asset Management no esté cualificada para hacer dicha oferta o invitación;
(c)  sea ilícito hacer dicha oferta o invitación.

Los ETFs referidos en esta página web no han estado y no estarán registrados conforme al U.S Securities Act de1933, por lo tanto, no pueden ser ofertados ni vendidos en los EE.UU sin registro previo o solo en caso de excepción de registro conforme al  al Securities Act. Por consiguiente, los ETFs listados en esta página web no pueden ser vendidos a “U.S persons”, ni transferidos a los Estados Unidos a menos que dicha transacción esté sujeta a los requisitos de registro conforme a la ley Americana.

Esta página web es de carácter comercial y no de carácter legal. No se garantiza la exactitud, exhaustividad o pertinencia de la información aunque ha sido establecida a partir de fuentes consideradas como fiables.
La información presentada en esta página web se basa en información de mercado constada en un momento dado que puede variar con posterioridad a su publicación. El valor de reembolso de los Lyxor ETFs puede ser inferior al montante de la inversión inicial. En el peor de los casos, los inversores podrían perder hasta la totalidad de su inversión, por lo que se recomienda a los inversores consultar la sección« factores de riesgo » del folleto del producto. El precio de algunos Lyxor ETFs puede ser sensible a riesgos de tipo de cambio entre la cotización del ETF y/o la divisa del índice y/o la divisa del componente del índice.

Todos los LyxorETFs presentados en esta página web han sido aprobados por la “Autorité des Marchés Financiers (AMF)” y son objeto de un folleto aprobado por la AMF y pasaporteado en la CNMV conforme a la Directiva 2003/71/CE. Dichos folletos están disponibles en esta página Web.

La documentación relativa a los Lyxor ETFs preverá métodos de ajuste y de sustitución para tener en cuenta que consecuencias tendría cualquier suceso extraordinario que afecte a uno o varios de los subyacentes de estos productos.

Antes de invertir en un Lyxor ETF, usted debe hacer su propia valoración del riesgo desde un punto de vista legal, fiscal y  contable, sin depender exclusivamente de la información que le proporcionamos y consultando, si lo estima necesario, sus propios asesores en la materia o cualquier otro asesor independiente.

El inversor de ETFs estará expuesto a los siguientes factores de riesgo: Riesgo de pérdida del capital invertido, al no existir ninguna garantía, como consecuencia de un movimiento desfavorable del Índice de Referencia, Riesgo de que el objetivo de gestión solo se cumpla parcialmente, Riesgo de contrapartida como resultado de la utilización de los instrumentos financieros (OTC) formalizados con un establecimiento de crédito. Se recomienda a los inversores que consulten la sección del folleto antes de invertir.

En la medida en que cumpla con la legislación aplicable, ninguna entidad del Grupo Société Générale acepta responsabilidad alguna por las consecuencias financieras o de cualquier otra naturaleza que resulten de la inversión en este producto.

Utilizamos las Cookies para asegurar el correcto funcionamiento de nuestro sitio web, y para recopilar datos estadísticos sobre usuarios de modo que podamos mejorar el sitio web. Si continúa navegando por este sitio web usted aceptará nuestro uso de las Cookies.Para más información o para modificar sus preferencias sobre CookiesHaga click aquí
05 mar 2018

Milestone or millstone for European equities?


With the Catalan crisis stalled, for now at least, all eyes have been on political risk in Italy and some arduous deal-making in Germany. After Sunday’s result, Italy is likely to lurch into some frenzied horse-trading, but where will Merkel’s new coalition of moderates get to and what does it all mean for European equities?  

EMU risk assets have in fact held up pretty well to all of the political stress of recent months, but the economic recovery still seems underpriced. The equity market remains around 15% below the highs of previous cycles.


Italian intrigue

Although the scaremongering did pick up prior to the election, the Five Star Movement was never going to get the majority it needed. A hung parliament was always the likeliest option – a slightly sullied status quo that won’t help progress much-needed reforms or trigger any major disruptions.

The markets and the FTSE MIB might be mollified by a result which doesn’t place the populists directly in power, but it won’t change our view on Italian equities. They may well get left behind this year unless actions taken in the next few days lead to some form of constructive majority government. Parties in Italy aren’t bound to their electoral allies post polling day, so some important decisions still lie ahead.

Should a centre right coalition be struck, we suspect we’ll see more positive progress on reform and therefore expect to adopt a stronger stance on the outlook both for the MIB and EMU risk assets overall. On the other hand, should Five Star swallow its words and form a coalition with the eurosceptic, anti-immigration League party, all bets are off.  


A grand-ish coalition

September’s election in Germany is a distant memory, yet negotiations to form a new government have taken five months – the longest in post-war German history. After renewing their seemingly fractured relationship, Angela Merkel’s conservative CDU party and the initially unwilling Social Democrats (SPD) have finally combined to secure her fourth term in office. The courtship has been more difficult this time around – she has had to surrender control of the key finance, foreign and employment ministries to make the breakthrough.  As a result, the direction the new government will take is hard to call.

The SPD was, essentially, strong-armed into ratifying the deal by voters. Had they not, they were faced with electoral extinction at the hands of the far-right AfD. A rigorous risk-off episode would have been inevitable. The will of the people, and the SPD’s natural will to power, were enough to see them over the line.  

We aren’t certain the SPD’s decision will do much to change what’s a positive outlook for the DAX in the short term. Their “yes” favours domestic demand, German consumers and euro area banks. 


Follow the money

Investors grew more wary of Europe in the latter part of last year given the three-pronged political risk. Appetite has however returned, especially in the US. Flows into eurozone equity ETFs are way ahead of where they were this time last year, despite the volatility of mid-February. Inflows have in fact exceeded those for US equities - potentially signalling the start of an asset allocation shift designed to exploit the valuation gap between the two markets.

Away from ETFs, long/short equity strategies and mutual funds have displayed similar results, with investors attracted by the alpha and beta potential of a two-speed Europe. The weekend’s results may just have made that an even more concrete prospect – provided you are picky. “Macronomic” progress in France and probable debt forgiveness for Greece mean they remain our preferred eurozone markets, but Germany’s outlook has just improved. 

Pick your ground

Signs of such selectivity are already apparent. Country-specific ETFs have enjoyed a sharp rise in inflows, mostly towards Germany. The DAX, with its many exporters, seems to be more driven by swings in EUR/USD and global growth prospects than it is by political concerns. The single currency’s weakness last month was clearly attractive. We expect more good news to follow, provided there’s no great appreciation in the euro from here. 


Lyxor’s European equity range

With Lyxor, you can choose between six broad European or eurozone equity ETFs – among them some of the oldest and largest you can find. And, with TERs starting from just 0.07%, big picture thinking won’t come cheaper. Of course, Europe is our home turf, so we’ve also built a range of single country ETFs built to exploit the best your market has to offer. Home in on household names with large-cap indices like the DAX, CAC or MIB, double up with our daily leveraged products or spot the next big thing with our mid-cap range

Read more on the range

Source: Lyxor Cross Asset & Equity Strategy. All data & opinion as at 5 March 2018 unless otherwise stated. Past performance is no guide to future returns. 


Risk Warning


THIS COMMUNICATION IS FOR ELIGIBLE COUNTERPARTIES OR PROFESSIONAL CLIENTS ONLY

Fund and charge data: Lyxor ETF, correct as at  05 March 2018.

This document is for the exclusive use of investors acting on their own account and categorized either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2004/39/EC. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on www.lyxoretf.com, and upon request to client-services-etf@lyxor.com.

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on www.lyxoretf.com. In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Lyxor International Asset Management (LIAM), société par actions simplifiée having its registered office at Tours Société Générale, 17 cours Valmy, 92800 Puteaux (France), 418 862 215 RCS Nanterre, is authorized and regulated by the Autorité des Marchés Financiers (AMF) under the UCITS Directive (2009/65/EU) and the AIFM Directive (2011/31/EU). LIAM is represented in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority).

Research disclaimer


Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website www.lyxoretf.com/compliance.

Conflicts of interest 

This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.

Connect with us on linkedin